Title : Beyond conventional antibiotics for the future treatment of methicillin-3 resistant Staphylococcus aureus infections : Two novel alternatives . 4 5 6

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inducible clindamycin resistance in Staphylococcus species.

  2014cited by this paper
• Synthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation

  2013cited by this paper
• Search method for inhibitors of Staphyloxanthin production by methicillin-resistant Staphylococcus aureus.

  2012cited by this paper
• Transferable Multidrug Resistance Plasmid Carrying cfr Associated with tet(L), ant(4′)-Ia, and dfrK Genes from a Clinical Methicillin-Resistant Staphylococcus aureus ST125 Strain

  2012cited by this paper
• Erratum to New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin

  2012cited by this paper
• Deciphering the Mode of Action of the Synthetic Antimicrobial Peptide Bac8c

  2011cited by this paper
• Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus

  2011cited by this paper
• Multifunctional cationic host defence peptides and their clinical applications

  2011cited by this paper
• IDSA GUIDELINES Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children

  2011cited by this paper
• Synthetic Cationic Peptide IDR-1002 Provides Protection against Bacterial Infections through Chemokine Induction and Enhanced Leukocyte Recruitment

  2010cited by this paper
• Strategies for the discovery and advancement of novel cationic antimicrobial peptides.

  2010cited by this paper
• Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli.

  2010cited by this paper
• Aureusimines in Staphylococcus aureus Are Not Involved in Virulence

  2010cited by this paper
• Therapeutic effect of (Z)-3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl) acrylonitrile (DMMA) against Staphylococcus aureus infection in a murine model.

  2010cited by this paper
• Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples.

  2010cited by this paper
• Potential therapeutic efficacy of a bactericidal–immunomodulatory fusion peptide against methicillin-resistant Staphylococcus aureus skin infection

  2010cited by this paper
• Molecular Docking Studies to Map the Binding Site of Squalene Synthase Inhibitors on Dehydrosqualene Synthase of Staphylococcus Aureus

  2010cited by this paper
• Novel peptide ligand directs liposomes toward EGF‐R high‐expressing cancer cells in vitro and in vivo

  2009cited by this paper
• Staphylococcus aureus Golden Pigment: Virulence Factor and Therapeutic Target

  2009cited by this paper
• Structure dependence of biological activities for primate cathelicidins

  2009cited by this paper
• Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus.

  2009cited by this paper
• Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.

  2009cited by this paper
• Antimicrobial peptide mimics for improved therapeutic properties.

  2009cited by this paper
• Method for Screening Compounds That Influence Virulence Gene Expression in Staphylococcus aureus

  2009cited by this paper
• Activity of the Novel Peptide Arminin against Multiresistant Human Pathogens Shows the Considerable Potential of Phylogenetically Ancient Organisms as Drug Sources

  2009cited by this paper
• Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors.

  2009cited by this paper
• The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion

  2009cited by this paper
• Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.

  2009cited by this paper
• Imcroporin, a New Cationic Antimicrobial Peptide from the Venom of the Scorpion Isometrus maculates

  2009cited by this paper
• Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

  2008cited by this paper
• Mucroporin, the First Cationic Host Defense Peptide from the Venom of Lychas mucronatus

  2008cited by this paper
• RNAIII-Inhibiting Peptide Enhances Healing of Wounds Infected with Methicillin-Resistant Staphylococcus aureus

  2008cited by this paper
• Pharmacokinetics and pharmacodynamics of Phor21‐βCG(ala), a lytic peptide conjugate

  2008cited by this paper
• A Potential New Pathway for Staphylococcus aureus Dissemination: The Silent Survival of S. aureus Phagocytosed by Human Monocyte-Derived Macrophages

  2008cited by this paper
• A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence

  2008cited by this paper
• A Novel Staphylococcus aureus Biofilm Phenotype Mediated by the Fibronectin-Binding Proteins, FnBPA and FnBPB

  2008cited by this paper
• Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide-lincosamide-streptogramin B.

  2008cited by this paper
• Cyclic peptide inhibitors of staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis.

  2008cited by this paper
• Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37

  2008cited by this paper
• Ceftobiprole

  2008cited by this paper
• An anti-infective peptide that selectively modulates the innate immune response

  2007cited by this paper
• Inactivation of traP Has No Effect on the Agr Quorum-Sensing System or Virulence of Staphylococcus aureus

  2007cited by this paper
• Activation of Inhibitors by Sortase Triggers Irreversible Modification of the Active Site*

  2007cited by this paper
• Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment

  2006cited by this paper
• Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application.

  2006cited by this paper
• Immunomodulatory Properties of Defensins and Cathelicidins

  2006cited by this paper
• Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

  2006cited by this paper
• N-Acylhomoserine Lactones Antagonize Virulence Gene Expression and Quorum Sensing in Staphylococcus aureus

  2006cited by this paper
• Antimicrobial peptides: therapeutic potential

  2006cited by this paper
• Design of a Peptibody Consisting of the Antimicrobial Peptide dhvar5 and a llama Variable Heavy‐chain Antibody Fragment

  2006cited by this paper
• Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.

  2006cited by this paper
• Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-371

  2006cited by this paper
• Antimicrobial activity of an abiotic host defense peptide mimic.

  2006cited by this paper
• Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide.

  2005cited by this paper
• Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity

  2005cited by this paper
• Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus

  2005cited by this paper
• Transient interference with staphylococcal quorum sensing blocks abscess formation.

  2005cited by this paper
• In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.

  2005cited by this paper
• Discovery of diarylacrylonitriles as a novel series of small molecule sortase A inhibitors.

  2004cited by this paper
• Effect of srtA and srtB gene expression on the virulence of Staphylococcus aureus in animal models of infection.

  2004cited by this paper
• Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.

  2004cited by this paper
• Omiganan Pentahydrochloride (MBI 226), a Topical 12-Amino-Acid Cationic Peptide: Spectrum of Antimicrobial Activity and Measurements of Bactericidal Activity

  2004cited by this paper
• Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment.

  2003cited by this paper
• Large-scale manufacture of peptide therapeutics by chemical synthesis

  2003cited by this paper
• Autoinduction and signal transduction in the regulation of staphylococcal virulence

  2003cited by this paper
• Antimicrobial Activity and Stability to Proteolysis of Small Linear Cationic Peptides with D‐Amino Acid Substitutions

  2002cited by this paper
• Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics.

  2002cited by this paper
• An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis

  2002cited by this paper
• Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.

  2002cited by this paper
• Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine

  2001cited by this paper
• Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.

  2001cited by this paper
• Epidemiology and Susceptibility of 3,051Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European SENTRY Study

  2001cited by this paper
• Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC.

  2000cited by this paper
• Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections.

  2000cited by this paper
• IB-367, a Protegrin Peptide with In Vitro and In Vivo Activities against the Microflora Associated with Oral Mucositis

  2000cited by this paper
• Estimation of Oral Bioavailability in the Rat by the Accelerated Infusion Technique

  2000cited by this paper
• Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide.

  1999cited by this paper
• Anti-cancer activity of targeted pro-apoptotic peptides

  1999cited by this paper
• Membrane channel formation by antimicrobial protegrins.

  1999cited by this paper
• Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall.

  1999cited by this paper
• In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog

  1998cited by this paper
• Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions.

  1998cited by this paper
• Estimation of Oral Bioavailability of a Long Half-Life Drug in Healthy Subjects

  1998cited by this paper
• The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.

  1998cited by this paper
• Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.

  1998cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of a New Squalene Synthase Inhibitor, BMS‐188494, in Healthy Volunteers

  1998cited by this paper
• An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma.

  1997cited by this paper
• Monoclonal antibody against bovine Lactoferricin and its epitopic site.

  1996cited by this paper
• An enzyme immunoassay for human defensins.

  1991cited by this paper
• Penicillin‐binding proteins of β‐lactam‐resistant strains of Staphylococcus aureus

  1985cited by this paper
• Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus

  1984cited by this paper
• Treatment of Staphylococcus aureus Endocarditis-Reply

  1977cited by this paper
• Staphylococcus aureus

  1948cited by this paper

• No citing papers are available for this paper.